Zydus Walks Away From US Dapagliflozin Appeal, ANDA Discontinued

ANDA Sponsor And AstraZeneca Disagreed On Chances Of Settlement

 
• By Dean Rudge
  
Blue Button Dismiss
A raft of ANDAs are tentatively approved • Source: Faysal Farhan / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products